Tag: Alzheimer’s disease
Research on Treatments for Alzheimer’s Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
TOKYO, Apr 18, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that “The Research on Treatments for Alzheimer’s Disease Based on its...
Top News
Breaking News
This Gene Increases the Risk of Alzheimer’s. Scientists Finally Know Why
At the turn of the 20th century, Dr. Alois Alzheimer noticed peculiar changes in a freshly removed brain. The brain had belonged to a...
Enable data sharing through federated learning: A policy approach for chief digital officers | Amazon Web Services
This is a guest blog post written by Nitin Kumar, a Lead Data Scientist at T and T Consulting Services, Inc.
...
Neural prosthetic aims to boost memory – Physics World
<a href="https://platoblockchain.net/wp-content/uploads/2024/03/neural-prosthetic-aims-to-boost-memory-physics-world-2.jpg" data-fancybox data-src="https://platoblockchain.net/wp-content/uploads/2024/03/neural-prosthetic-aims-to-boost-memory-physics-world-2.jpg" data-caption="Image recall task The research team delivered neurostimulation to study participants during visual recognition memory tasks, finding significant changes in...
Eisai Invests in C2N to Support Simplifying the Diagnosis of Early Alzheimer’s Disease to Better Serve Patients
TOKYO, Mar 6, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. has decided to invest up...
IGC Pharma Reports Third Quarter Fiscal 2024 Results
POTOMAC, Md.–(BUSINESS WIRE)–#AD–IGC Pharma, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2024...
Financial middle management: the next major fintech opportunity for financial services innovators?
A significant shift is occurring in the demographic landscape, presenting unique challenges and opening new avenues for innovation, particularly in financial services. This demographic...
What Your Brain Is Doing When You’re Not Doing Anything | Quanta Magazine
IntroductionWhenever you’re actively performing a task — say, lifting weights at the gym or taking a hard exam — the parts of your brain...
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer’s Mouse Model
– The Company is targeting a Phase 1 trial in 2024 –
POTOMAC, Md.–(BUSINESS WIRE)–#AD–IGC Pharma, Inc. (“IGC Pharma,” “IGC,” or the “Company”) (NYSE American:...
Eisai Commences Fully-Fledged Business Activities at Pharma Sales Subsidiary in South Africa
TOKYO, Feb 1, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that fully-fledged operations have begun at Eisai Pharmaceuticals Africa (Pty) Ltd...
Focused ultrasound plus plaque-reducing drugs could slow Alzheimer’s progression – Physics World
<a href="https://platoblockchain.net/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-fancybox data-src="https://platoblockchain.net/wp-content/uploads/2024/01/focused-ultrasound-plus-plaque-reducing-drugs-could-slow-alzheimers-progression-physics-world-3.jpg" data-caption="Deliver the drugs Researchers at the West Virginia University Rockefeller Neuroscience Institute, shown in the MRI...
PointClickCare Acquires CPSI Subsidiary, American HealthTech
CPSI selects PointClickCare to support AHT customers with access to a best-in-class suite of products and solutions, and the most expansive care collaboration network
TORONTO–(BUSINESS...
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates
– Achieved Full Year 2023 Preliminary Global Net Product Revenues of $1,241 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 39% Annual Growth (39%...
Latest Intelligence
